<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Int J Health Geogr</journal-id>
    <journal-id journal-id-type="iso-abbrev">Int J Health Geogr</journal-id>
    <journal-title-group>
      <journal-title>International Journal of Health Geographics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1476-072X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6771109</article-id>
    <article-id pub-id-type="publisher-id">185</article-id>
    <article-id pub-id-type="doi">10.1186/s12942-019-0185-9</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Methodology</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Development of the Australian Cancer Atlas: spatial modelling, visualisation, and reporting of estimates</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Duncan</surname>
          <given-names>Earl W.</given-names>
        </name>
        <address>
          <email>earl.duncan@qut.edu.au</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cramb</surname>
          <given-names>Susanna M.</given-names>
        </name>
        <address>
          <email>susanna.cramb@qut.edu.au</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Aitken</surname>
          <given-names>Joanne F.</given-names>
        </name>
        <address>
          <email>JoanneAitken@cancerqld.org.au</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mengersen</surname>
          <given-names>Kerrie L.</given-names>
        </name>
        <address>
          <email>k.mengersen@qut.edu.au</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8576-8868</contrib-id>
        <name>
          <surname>Baade</surname>
          <given-names>Peter D.</given-names>
        </name>
        <address>
          <phone>+61 73634 5317</phone>
          <email>PeterBaade@cancerqld.org.au</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000089150953</institution-id><institution-id institution-id-type="GRID">grid.1024.7</institution-id><institution>ARC Centre of Excellence for Mathematical and Statistical Frontiers, </institution><institution>Queensland University of Technology (QUT), </institution></institution-wrap>Brisbane, Australia </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000089150953</institution-id><institution-id institution-id-type="GRID">grid.1024.7</institution-id><institution>School of Mathematics, Science and Engineering Faculty, </institution><institution>Queensland University of Technology (QUT), </institution></institution-wrap>Brisbane, Australia </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9761 7912</institution-id><institution-id institution-id-type="GRID">grid.430282.f</institution-id><institution>Cancer Council Queensland, </institution></institution-wrap>PO Box 201, Spring Hill, Brisbane, QLD 4004 Australia </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0437 5432</institution-id><institution-id institution-id-type="GRID">grid.1022.1</institution-id><institution>Menzies Health Institute Queensland, Griffith University, </institution></institution-wrap>Gold Coast, Australia </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution>School of Public Health, </institution><institution>The University of Queensland, </institution></institution-wrap>Brisbane, Australia </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000000089150953</institution-id><institution-id institution-id-type="GRID">grid.1024.7</institution-id><institution>School of Research-Public Health, </institution><institution>Queensland University of Technology, </institution></institution-wrap>Brisbane, Australia </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0473 0844</institution-id><institution-id institution-id-type="GRID">grid.1048.d</institution-id><institution>Institute for Resilient Regions, </institution><institution>University of Southern Queensland, </institution></institution-wrap>Brisbane, Australia </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>1</day>
      <month>10</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>1</day>
      <month>10</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>18</volume>
    <elocation-id>21</elocation-id>
    <history>
      <date date-type="received">
        <day>17</day>
        <month>4</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>9</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">It is well known that the burden caused by cancer can vary geographically, which may relate to differences in health, economics or lifestyle. However, to date, there was no comprehensive picture of how the cancer burden, measured by cancer incidence and survival, varied by small geographical area across Australia.</p>
      </sec>
      <sec>
        <title>Methods</title>
        <p id="Par2">The Atlas consists of 2148 Statistical Areas level 2 across Australia defined by the Australian Statistical Geography Standard which provide the best compromise between small population and small area. Cancer burden was estimated for males, females, and persons separately, with 50 unique sex-specific (males, females, all persons) cancer types analysed. Incidence and relative survival were modelled with Bayesian spatial models using the Leroux prior which was carefully selected to provide adequate spatial smoothing while reflecting genuine geographic variation. Markov Chain Monte Carlo estimation was used because it facilitates quantifying the uncertainty of the posterior estimates numerically and visually.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par3">The results of the statistical model and visualisation development were published through the release of the Australian Cancer Atlas (<ext-link ext-link-type="uri" xlink:href="https://atlas.cancer.org.au">https://atlas.cancer.org.au</ext-link>) in September, 2018. The Australian Cancer Atlas provides the first freely available, digital, interactive picture of cancer incidence and survival at the small geographical level across Australia with a focus on incorporating uncertainty, while also providing the tools necessary for accurate estimation and appropriate interpretation and decision making.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par4">The success of the Atlas will be measured by how widely it is used by key stakeholders to guide research and inform decision making. It is hoped that the Atlas and the methodology behind it motivates new research opportunities that lead to improvements in our understanding of the geographical patterns of cancer burden, possible causes or risk factors, and the reasons for differences in variation between cancer types, both within Australia and globally. Future versions of the Atlas are planned to include new data sources to include indicators such as cancer screening and treatment, and extensions to the statistical methods to incorporate changes in geographical patterns over time.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Australian Cancer Atlas</kwd>
      <kwd>Cancer incidence</kwd>
      <kwd>Relative survival</kwd>
      <kwd>Spatial smoothing</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>FrontierSI</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001168</institution-id>
            <institution>Cancer Council Queensland</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Australian Institute of Health and Welfare</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001793</institution-id>
            <institution>Queensland University of Technology</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par16">There is a long history of studies showing that where you live matters [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. This can relate to health, economics or lifestyle. It is no different with cancer. The existence of significant geographic variation in cancer incidence and mortality is well known [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], however, most analyses until now have been based on relatively broad or socioeconomically heterogenous geographic areas, precluding detailed area-based comparisons. A number of health-related and cancer-specific interactive, online atlases have been previously released in other countries, including, for example, the Environmental Health Atlas (UK), the National Cancer Institute Cancer Atlas (USA), The Centre for Disease Control Interactive Cancer Atlas (USA), and cancer mortality maps in Spain by province and municipal level [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. However to date, there has been no comprehensive atlas of cancer in Australia.</p>
    <p id="Par17">The Australian Cancer Atlas [<xref ref-type="bibr" rid="CR12">12</xref>], launched in September 2018, provides the first digital, interactive picture of cancer burden at the small geographical level across Australia, including modelled estimates of both cancer incidence and survival, and incorporating the statistical methodology and visualisation methods that are required for accurate estimation, interpretation and decision making.</p>
    <p id="Par18">Given the increasing number of cancer atlases available internationally, the variety of statistical methods and visualisation techniques utilised, and the inferences that may be drawn from the atlas estimates by researchers, managers, and policy makers, it is our aim here to outline the rationale and development of the statistical models used for the Australian Cancer Atlas, and the method of visualising the estimates from those models. In doing so, it is hoped that these statistical and visualisation methods may be used more widely, thus creating opportunities for more direct comparisons between the geographical patterns of cancer burden and possible causes or risk factors, both within Australia and across other countries.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Geographical areas</title>
      <p id="Par19">The geographical areas that compose the Atlas are Statistical Areas level 2 (SA2s), defined by the Australian Statistical Geography Standard (ASGS) July 2011 edition [<xref ref-type="bibr" rid="CR13">13</xref>]. SA2s broadly represent communities that interact together socially and economically, and cover Australia without gaps or overlap [<xref ref-type="bibr" rid="CR14">14</xref>]. Australian SA2s range in size from &lt; 1 to 520,000 km<sup>2</sup>, and in 2014 had a median population of 8991 (range 0 to 54,773). There are two main reasons for using SA2s: they provide the best compromise between small population and small area to enable modelling at a “small area” scale; and they are the smallest geographical areas to which cancer registries routinely assign patient residence at diagnosis.</p>
      <p id="Par20">Of the 2214 SA2s covering Australia, those with no residential population (n = 28), no physical location (comprising ‘Migratory–Offshore–Shipping’ and ‘No usual address’ codes for each State and Territory) (n = 18), fewer than five residents on average per year during 2010–2014 (n = 17), and those very remote islands &gt; 500 km from the Australian mainland [Christmas Island, Cocos Island and Lord Howe Island (n = 3)] were excluded. This left 2148 SA2s for which modelled estimates are provided in the Atlas.</p>
    </sec>
    <sec id="Sec4">
      <title>Cancer types and outcome measures</title>
      <p id="Par21">The cancer types, classified using the 2016 version of the International Classification of Diseases (ICD-10) disease code (Table <xref rid="Tab1" ref-type="table">1</xref>), [<xref ref-type="bibr" rid="CR15">15</xref>] were selected based predominately on those with higher numbers of diagnoses. Due to discrepancies between how the state and territory cancer registries assigned invasive status during the time period of interest (2005–2014), bladder cancer (ICD-10 C67) was excluded from the analysis. Breast cancer was restricted to females only, due to an insufficient number of breast cancers diagnosed among males for analysis. Due to reporting estimates by males, females and all persons separately, 50 unique sex-specific (males, females, all persons) cancer types were included in the analysis.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Time period and data sparsity by type of cancer </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Cancer type</th><th align="left" rowspan="2">Total diagnoses</th><th align="left" colspan="3">Number of SA2s with 0 counts</th><th align="left" colspan="3">Number of SA2s with 0 people at risk 2006–2014</th></tr><tr><th align="left">M</th><th align="left">F</th><th align="left">P</th><th align="left">M</th><th align="left">F</th><th align="left">P</th></tr></thead><tbody><tr><td align="left" colspan="8">2010–2014</td></tr><tr><td align="left"> All cancers C00–C97, D45, D46, D47.1, D47.3–D47.5 </td><td char="." align="char">615,192</td><td align="left">29</td><td align="left">42</td><td align="left">26</td><td align="left">21</td><td align="left">31</td><td align="left">18</td></tr><tr><td align="left"> Bowel cancer (C18–C20)</td><td char="." align="char">74,223</td><td align="left">71</td><td align="left">88</td><td align="left">61</td><td align="left">60</td><td align="left">74</td><td align="left">48</td></tr><tr><td align="left"> Lung cancer (C33–C34)</td><td char="." align="char">54,792</td><td align="left">90</td><td align="left">115</td><td align="left">74</td><td align="left">71</td><td align="left">91</td><td align="left">64</td></tr><tr><td align="left"> Melanoma of the skin (C43)</td><td char="." align="char">61,310</td><td align="left">95</td><td align="left">110</td><td align="left">73</td><td align="left">74</td><td align="left">88</td><td align="left">42</td></tr><tr><td align="left"> Breast cancer<sup>a</sup> (C50)</td><td char="." align="char">77,992</td><td align="left">–</td><td align="left">62</td><td align="left">–</td><td align="left">–</td><td align="left">46</td><td align="left">–</td></tr><tr><td align="left"> Prostate cancer<sup>b</sup> (C61)</td><td char="." align="char">99,681</td><td align="left">57</td><td align="left">–</td><td align="left">–</td><td align="left">41</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" colspan="8">2005–2014</td></tr><tr><td align="left"> Head and neck cancer (C00–C14, C30–C32)</td><td char="." align="char">40,441</td><td align="left">72</td><td align="left">211</td><td align="left">67</td><td align="left">73</td><td align="left">223</td><td align="left">67</td></tr><tr><td align="left"> Oesophageal cancer (C15)</td><td char="." align="char">13,362</td><td align="left">252</td><td align="left">700</td><td align="left">170</td><td align="left">264</td><td align="left">751</td><td align="left">177</td></tr><tr><td align="left"> Stomach cancer (C16)</td><td char="." align="char">20,084</td><td align="left">192</td><td align="left">433</td><td align="left">139</td><td align="left">201</td><td align="left">476</td><td align="left">146</td></tr><tr><td align="left"> Liver cancer (C22)</td><td char="." align="char">14,985</td><td align="left">244</td><td align="left">660</td><td align="left">172</td><td align="left">264</td><td align="left">728</td><td align="left">186</td></tr><tr><td align="left"> Pancreatic cancer (C25)</td><td char="." align="char">26,939</td><td align="left">162</td><td align="left">223</td><td align="left">103</td><td align="left">176</td><td align="left">253</td><td align="left">106</td></tr><tr><td align="left"> Cervical cancer<sup>a</sup> (C53)</td><td char="." align="char">7930</td><td align="left">–</td><td align="left">302</td><td align="left">–</td><td align="left">–</td><td align="left">308</td><td align="left">–</td></tr><tr><td align="left"> Uterine cancer<sup>a</sup> (C54–C55)</td><td char="." align="char">22,020</td><td align="left">–</td><td align="left">101</td><td align="left">–</td><td align="left">–</td><td align="left">105</td><td align="left">–</td></tr><tr><td align="left"> Ovarian cancer<sup>a</sup> (C56)</td><td char="." align="char">13,267</td><td align="left">–</td><td align="left">199</td><td align="left">–</td><td align="left">–</td><td align="left">211</td><td align="left">–</td></tr><tr><td align="left"> Kidney cancer (C64)</td><td char="." align="char">28,212</td><td align="left">114</td><td align="left">248</td><td align="left">91</td><td align="left">116</td><td align="left">252</td><td align="left">92</td></tr><tr><td align="left"> Brain cancer (C71)</td><td char="." align="char">14,933</td><td align="left">255</td><td align="left">392</td><td align="left">156</td><td align="left">269</td><td align="left">418</td><td align="left">165</td></tr><tr><td align="left"> Thyroid cancer (C73)</td><td char="." align="char">21,895</td><td align="left">443</td><td align="left">189</td><td align="left">123</td><td align="left">452</td><td align="left">192</td><td align="left">125</td></tr><tr><td align="left"> Non-Hodgkin lymphoma (C82–C86)</td><td char="." align="char">45,169</td><td align="left">96</td><td align="left">146</td><td align="left">71</td><td align="left">96</td><td align="left">152</td><td align="left">71</td></tr><tr><td align="left"> Myeloma (C90)</td><td char="." align="char">15,264</td><td align="left">279</td><td align="left">431</td><td align="left">172</td><td align="left">294</td><td align="left">456</td><td align="left">182</td></tr><tr><td align="left"> Leukaemia (C91–C95)</td><td char="." align="char">30,737</td><td align="left">124</td><td align="left">200</td><td align="left">88</td><td align="left">134</td><td align="left">217</td><td align="left">91</td></tr></tbody></table><table-wrap-foot><p><italic>M</italic> males, <italic>F</italic> females, <italic>P</italic> persons</p><p><sup>a</sup> Females only</p><p><sup>b</sup> Males only note that only the 2148 SA2s considered to have a residential population are included</p></table-wrap-foot></table-wrap>
</p>
      <sec id="Sec5">
        <title>Incidence</title>
        <p id="Par22">Cancer incidence refers to the number of new cancer cases diagnosed within a given time period. In order to make comparisons of cancer incidence between small areas with differing population size and age structure, incidence rates were compared rather than the number of cancers diagnosed. Indirect standardisation through the standardised incidence ratio (SIR) [<xref ref-type="bibr" rid="CR16">16</xref>] is the preferred method of standardisation when there are very small numbers in some age groups, because it removes the substantial sampling variation that would be present in this situation with direct standardisation [<xref ref-type="bibr" rid="CR17">17</xref>]. The SIR reflects the area-specific incidence rate relative to the Australian average. It is the ratio of the observed cancer cases to the expected number of cases, the latter adjusting for differences in population between SA2s and differences in age structure of the population within an SA2.</p>
      </sec>
      <sec id="Sec6">
        <title>Survival</title>
        <p id="Par23">Survival is a key measure of cancer patient care [<xref ref-type="bibr" rid="CR18">18</xref>]. Consistent with standard reporting from population-based cancer registries [<xref ref-type="bibr" rid="CR18">18</xref>], the relative survival framework was used in this Atlas. Relative survival is an estimate of net survival, which aims to measure the deaths that are specifically associated with a cancer diagnosis. For the Atlas, relative survival estimates up to 5 years after diagnosis were generated using the period method [<xref ref-type="bibr" rid="CR19">19</xref>]. The relative survival models estimate the excess hazard ratio (EHR), which, for a given geographical area, is interpreted as the risk of dying from a given cancer within 5 years after diagnosis relative to the Australian average risk [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>Time period</title>
        <p id="Par24">To maximise the robustness of the spatial estimates due to the sparse data (Table <xref rid="Tab1" ref-type="table">1</xref>), the cancer cases were aggregated over multiple years. For cancer incidence, the five most commonly diagnosed cancers and the category “all cancers” used data aggregated over the latest 5-year period (2010–2014), while all other cancer types combined cases over the latest 10-year period (2005–2014). For the cancer survival estimates, data were aggregated across the entire ‘at-risk’ time period for which population mortality data were available, namely 2006–2014. Given that the period method was being used to calculate relative survival, cases included in the survival analyses could have been diagnosed from 2001 onwards.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Data sources</title>
      <p id="Par25">De-identified individual level data for each case of cancer diagnosed in Australian residents during the specified period were obtained from the Australian Cancer Database (ACD), which is maintained by the Australian Institute of Health and Welfare (AIHW) [<xref ref-type="bibr" rid="CR20">20</xref>]. The ACD contains records on all primary invasive cancer cases (excluding basal and squamous cell carcinoma of the skin) diagnosed in Australian residents and notified to one of Australia’s eight state and territory population cancer registries. Australia has mandatory cancer notification, ensuring virtually complete population incidence data. At the time of analysis, the ACD contained records of cases diagnosed from 1982 to 2014 (1982–2013 in New South Wales), although geographical information for cancer cases at the SA2 level was only available from 1996 onward. Cases with missing SA2 details (0.8% of all cancers) were excluded from the analyses.</p>
      <p id="Par26">Estimated residential population data grouped for Australia by SA2, year, sex, and 5-year age group (to 85+ years) were obtained from the Australian Bureau of Statistics (ABS) [<xref ref-type="bibr" rid="CR21">21</xref>]. These population data were only available from 2001 onward.</p>
      <p id="Par27">Unit record population mortality data for all causes of death combined were only available from the Registry of Births, Deaths and Marriages [<xref ref-type="bibr" rid="CR22">22</xref>] for the period during 2006 to 2014. The unit record data included details about sex, year of death, age, and SA2 at death.</p>
    </sec>
    <sec id="Sec9">
      <title>Statistical models</title>
      <sec id="Sec10">
        <title>Spatial smoothing</title>
        <p id="Par28">Due to the inherent variation that is associated with low numbers in small geographical areas, spatial smoothing was used to increase the stability of the resulting estimates and protect confidentiality. In effect, spatial smoothing borrows information from neighbouring areas, seeking to estimate the underlying rate, rather than simply reporting the more pronounced random variation arising from very low numbers of observed cases when there are few residents. Spatial smoothing also alleviates the effect of the somewhat arbitrary nature of boundaries defining the geographical areas.</p>
        <p id="Par29">There are several ways to carry out statistical smoothing. For the Atlas we used Bayesian spatial models, in particular, conditional autoregressive models. Two main advantages of this approach were that Bayesian models readily incorporate the spatial correlation between areas in a natural manner as part of the prior information, recognising that adjoining geographical areas are likely to have some similar characteristics, and also that the probabilistic description of each of the unknown quantities provides a unique capacity to better quantify the extent of uncertainty around the spatial estimates.</p>
        <p id="Par30">The use of prior distributions to specify the unknown parameters is especially helpful for spatial parameters as it imposes a structure on the underlying stochastic process that is consistent with Tobler’s first law of geography, namely that “near things are more related than distant things” [<xref ref-type="bibr" rid="CR23">23</xref>]. The resulting spatial smoothing, or shrinkage, pulls posterior estimates towards a local or global mean, improving the stability of the estimates, especially areas with small populations, thus providing more robust estimates [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The extent of the smoothing depends on both the data and the specific prior distribution used.</p>
        <p id="Par31">Parametric Bayesian models provide a posterior distribution for the unknown parameters, not just a point estimate. This is helpful in understanding the uncertainty in the estimates [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Estimates obtained from Markov Chain Monte Carlo (MCMC) sampling are particularly useful as several statistics such as credible intervals around the estimate and probability that the estimate reflects a real difference to the Australian average can be derived which quantify uncertainty from several different perspectives.</p>
      </sec>
      <sec id="Sec11">
        <title>Spatial weights</title>
        <p id="Par32">A feature shared by all spatial prior distributions is the specification of spatial proximity between the random effects for each pair of areas. This usually takes the form of a spatial weights matrix, <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{W}}$$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="bold">W</mml:mi></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq1.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. There are many ways to define spatial proximity, which can be either continuous, e.g. distance between areas, or discrete, e.g. belonging to the “neighbourhood” of adjacent areas. The most common definition is the binary, first-order, adjacency weights matrix which has elements<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w_{ij} = \left\{ {\begin{array}{*{20}l} 1 \hfill &amp; {{\text{if areas}} \;i\;{\text{and}}\;j\;{\text{are adjacent}}} \hfill \\ 0 \hfill &amp; {\text{otherwise}} .\hfill \\ \end{array} } \right.$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="" open="{" separators=""><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mrow><mml:mtext>if areas</mml:mtext></mml:mrow><mml:mspace width="0.277778em"/><mml:mi>i</mml:mi><mml:mspace width="0.277778em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.277778em"/><mml:mi>j</mml:mi><mml:mspace width="0.277778em"/><mml:mrow><mml:mtext>are adjacent</mml:mtext></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtext>otherwise</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>
</p>
        <p id="Par33">This is the specification used in the Atlas, where SA2s are considered adjacent if they share a common land boundary of any length (so a SA2 wholly enclosed within another SA2 is considered adjacent to that SA2 and thus only has one neighbour). Under this definition, there were 12 island SA2s without neighbours. To enable spatial smoothing for these areas, at least one non-adjacent area was assigned as a neighbour. This was usually the mainland area connected by a bridge or ferry service, or failing that, the closest mainland point.</p>
        <p id="Par34">Although different specifications of the weights matrix can impact smoothing and lead to different inference on the spatial patterns, weights based on a distance decay function are usually deemed more suitable when the areas vary greatly in shape and size [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], or the population varies in size or age structure [<xref ref-type="bibr" rid="CR33">33</xref>]. We chose binary adjacency weights for several reasons. First, alternative weights such as those based on distances between area centroids do not automatically induce the Markov property [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], whereas a sparse spatial weights matrix is computationally advantageous. Second, distance-based weights with a high rate of decay as is commonly seen in disease atlases tend to become similar to row-standardised, binary, adjacency weights [<xref ref-type="bibr" rid="CR36">36</xref>], which seemed counterproductive. Conversely, a low rate of decay increases the region of influence implied by the spatial weights matrix, which may imply unrealistic spatial dependencies between the areas [<xref ref-type="bibr" rid="CR36">36</xref>]. Fewer neighbours were not only computationally advantageous, but also tended to perform at least as well as models with more neighbours [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Given the vast differences in the size of SA2s in Australia, we also found that distance-based weights, with a suitable cut-off to retain the Markov property, resulted in excessively large or small regions of influence. Third, adjacency-based weights complement the discrete nature of the observed data [<xref ref-type="bibr" rid="CR30">30</xref>], and grant the straightforward interpretation of including the average response values of the neighbouring areas as an extra predictor [<xref ref-type="bibr" rid="CR28">28</xref>]. Fourth, adjacency-based weights are easy to implement and alternative definitions do not necessarily improve results [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Moreover, an investigation of different spatial models (see Cramb et al. [<xref ref-type="bibr" rid="CR37">37</xref>]) and sensitivity analyses conducted as part of the development of the Atlas indicate that the type of model and the hyperprior controlling the variance of each spatial random effect has a greater influence on smoothing than the spatial weights.</p>
      </sec>
      <sec id="Sec12">
        <title>Bayesian hierarchical models</title>
        <p id="Par35">The models chosen for cancer incidence, and to some extent, relative survival, were based on the recommendations from Cramb et al. [<xref ref-type="bibr" rid="CR37">37</xref>]. In addition to the choice of neighbourhoods via the spatial weights, described above, a range of smoothing approaches across the nominated neighbourhoods are possible. Models may employ the same smoothing parameter consistently over the entire region (‘global smoothing’) or allow it to vary geographically based on specific characteristics such as geographical, social and administrative measures (‘local smoothing’). Furthermore, there are choices to be made about the underlying model, the sampling distribution to use for the data, the inclusion of fixed and/or random effects, and the specification of the prior distributions for the unknown parameters. A range of smoothing approaches and also model forms were considered for the Atlas, including parametric and semi-parametric models. The final choice was made by comparing the performance of each model and spatial prior configuration across a range of criteria, including goodness-of-fit, computation time, tendency to under- or over-smooth, and plausibility of estimates.</p>
        <p id="Par36">The model chosen for both cancer incidence and relative survival was that proposed by Leroux et al. [<xref ref-type="bibr" rid="CR38">38</xref>]. The Leroux model was favoured over other spatial models including the popular BYM model [<xref ref-type="bibr" rid="CR39">39</xref>] because it provided the best compromise between the aforementioned criteria [<xref ref-type="bibr" rid="CR37">37</xref>]. This model is a specific case of the generic three-stage hierarchical model proposed by Best et al. [<xref ref-type="bibr" rid="CR40">40</xref>] for the purpose of disease mapping.</p>
        <sec id="Sec13">
          <title>Incidence model</title>
          <p id="Par37">The cancer incidence model is given by,<disp-formula id="Equa"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} &amp; y_{i} \sim {\text{Poisson}}\left( {E_{i} e^{{\theta_{i} }} } \right)\quad {\text{for}} \;i = 1, \ldots ,2148 {\text{SA}}2{\text{s}} \hfill \\ &amp; \quad \theta_{i} \sim \beta_{0} + S_{i} \hfill \\ \end{aligned}$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Poisson</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup></mml:mrow></mml:mfenced><mml:mspace width="1em"/><mml:mtext>for</mml:mtext><mml:mspace width="0.277778em"/><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>2148</mml:mn><mml:mtext>SA</mml:mtext><mml:mn>2</mml:mn><mml:mtext>s</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mspace width="1em"/><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq2"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{y}_{\varvec{i}}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq2.gif"/></alternatives></inline-formula> is the observed number of cases for the <inline-formula id="IEq3"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq3.gif"/></alternatives></inline-formula> area, <inline-formula id="IEq4"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$E_{i}$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq4.gif"/></alternatives></inline-formula> is the expected number of cases, <inline-formula id="IEq5"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\theta_{i}$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq5.gif"/></alternatives></inline-formula> is the log-SIR, <inline-formula id="IEq6"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta_{0}$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq6.gif"/></alternatives></inline-formula> is the overall level of log-SIR (a fixed effect), and <inline-formula id="IEq7"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$S_{i}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq7.gif"/></alternatives></inline-formula> is the spatial random effect modelled by the Leroux prior<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$S_{i} |\varvec{S}_{\backslash i} \sim {\mathcal{N}}\left( {\frac{{\rho \mathop \sum \nolimits_{j} w_{ij} S_{j} }}{{\rho \mathop \sum \nolimits_{j} w_{ij} + 1 - \rho }}, \frac{{\sigma_{S}^{2} }}{{\rho \mathop \sum \nolimits_{j} w_{ij} + 1 - \rho }}} \right)$$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">S</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="true">\</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>ρ</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>ρ</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>
</p>
          <p id="Par38">Here <inline-formula id="IEq8"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w_{ij}$$\end{document}</tex-math><mml:math id="M22"><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq8.gif"/></alternatives></inline-formula> are the elements of the spatial neighbourhood matrix defined in Eq. (<xref rid="Equ1" ref-type="">1</xref>), and <inline-formula id="IEq9"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\rho$$\end{document}</tex-math><mml:math id="M24"><mml:mi>ρ</mml:mi></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq9.gif"/></alternatives></inline-formula> determines the spatial autocorrelation between the areas. The modelled estimates are effectively age-adjusted since the expected counts take into account the population size and age-structure. The prior distributions for the remaining parameters were weakly informative, specifically,<disp-formula id="Equb"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{*{20}c} {\beta_{0} \text{ }\sim { \mathcal{N}}\left( {0, 10^{5} } \right)} \\ {\sigma_{S}^{2} \text{ }\sim { \mathcal{I}\mathcal{G}}\left( {1, 0.01} \right)} \\ {\rho \sim {\text{Uniform}}\left( {0, 1} \right).} \\ \end{array}$$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mspace width="0.333333em"/><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>5</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mspace width="0.333333em"/><mml:mo>∼</mml:mo><mml:mrow><mml:mi mathvariant="script">I</mml:mi><mml:mi mathvariant="script">G</mml:mi></mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mi>ρ</mml:mi><mml:mo>∼</mml:mo><mml:mtext>Uniform</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equb.gif" position="anchor"/></alternatives></disp-formula>where the inverse Gamma distribution <inline-formula id="IEq10"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal{I}\mathcal{G}}\left( { \cdot ,\text{ } \cdot } \right)$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mrow><mml:mi mathvariant="script">I</mml:mi><mml:mi mathvariant="script">G</mml:mi></mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mo>·</mml:mo><mml:mo>,</mml:mo><mml:mspace width="0.333333em"/><mml:mo>·</mml:mo></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq10.gif"/></alternatives></inline-formula> is parameterised in terms of shape and scale. See the section “<xref rid="Sec17" ref-type="sec">Sensitivity analyses</xref>” for further discussion of these priors. The key output from this model and reported in the Atlas is the SIR, given by <inline-formula id="IEq11"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${ \exp }\left( {\theta_{i} } \right)$$\end{document}</tex-math><mml:math id="M30"><mml:mrow><mml:mo>exp</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq11.gif"/></alternatives></inline-formula>.</p>
        </sec>
        <sec id="Sec14">
          <title>Relative survival model</title>
          <p id="Par39">The relative survival model is closely based on that proposed by Fairley et al. [<xref ref-type="bibr" rid="CR41">41</xref>] except that the spatial random effect was modelled by the Leroux prior rather than the BYM prior [<xref ref-type="bibr" rid="CR39">39</xref>]. The likelihood for the number of deaths observed for the <inline-formula id="IEq12"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M32"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq12.gif"/></alternatives></inline-formula> area in the <inline-formula id="IEq13"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$k{\text{th}}$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>k</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq13.gif"/></alternatives></inline-formula> strata and <inline-formula id="IEq14"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t{\text{th}}$$\end{document}</tex-math><mml:math id="M36"><mml:mrow><mml:mi>t</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq14.gif"/></alternatives></inline-formula> follow-up interval is Poisson,<disp-formula id="Equc"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{itk} \sim {\text{Poisson}}\left( {\mu_{itk} } \right)$$\end{document}</tex-math><mml:math id="M38" display="block"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Poisson</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equc.gif" position="anchor"/></alternatives></disp-formula>for <inline-formula id="IEq15"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i = 1, \ldots ,2148$$\end{document}</tex-math><mml:math id="M40"><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>2148</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq15.gif"/></alternatives></inline-formula> areas, <inline-formula id="IEq16"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$k = 1, \ldots ,K$$\end{document}</tex-math><mml:math id="M42"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq16.gif"/></alternatives></inline-formula> age-sex-site strata, and <inline-formula id="IEq17"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t = 1, \ldots ,5$$\end{document}</tex-math><mml:math id="M44"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq17.gif"/></alternatives></inline-formula> follow-up years. The value of <italic>K</italic> depends on the cancer being modelled, but in general, it accounts for broad age groups (15–54, 55–64, 65–74 and 74–89 years), and for all persons only, sex (males, females). These broad age groups were chosen based on the frequency distribution of the observed cancers diagnosed, with the intention of relatively equal numbers of cancers within each age group. The alternative option, equal-spaced age ranges, would have increased the sparsity of data within younger ages, so was not considered further. In addition, for the aggregated cancer groups of “all cancers combined” and “head and neck cancers”, <italic>K</italic> also included cancer site.</p>
          <p id="Par40">The expected number of deaths due to any cause, <inline-formula id="IEq18"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu_{itk}$$\end{document}</tex-math><mml:math id="M46"><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq18.gif"/></alternatives></inline-formula>, is then modelled using the link function,<disp-formula id="Equd"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\log \left( {\mu_{itk} - d_{itk}^{*} } \right) = \log \left( {y_{itk} } \right) + \alpha_{t} + \beta_{1} x_{1,itk} + \cdots + \beta_{K} x_{K,itk} + S_{i}$$\end{document}</tex-math><mml:math id="M48" display="block"><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msubsup><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo>⋯</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equd.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq19"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{itk}^{*}$$\end{document}</tex-math><mml:math id="M50"><mml:msubsup><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq19.gif"/></alternatives></inline-formula> is the expected number of deaths due to causes other than the cancer of interest, <inline-formula id="IEq20"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y_{itk}$$\end{document}</tex-math><mml:math id="M52"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">itk</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq20.gif"/></alternatives></inline-formula> is an offset parameter for person-time at risk, <inline-formula id="IEq21"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha_{t}$$\end{document}</tex-math><mml:math id="M54"><mml:msub><mml:mi>α</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq21.gif"/></alternatives></inline-formula> is a year-specific intercept, <inline-formula id="IEq22"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x_{1,itk} , \ldots ,x_{K,itK}$$\end{document}</tex-math><mml:math id="M56"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq22.gif"/></alternatives></inline-formula> are indicator variables relating to the age–sex-site strata. The spatial random effect, <inline-formula id="IEq23"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$S_{i}$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq23.gif"/></alternatives></inline-formula>, is modelled by the Leroux prior, Eq. (<xref rid="Equ2" ref-type="">2</xref>), as it was for the incidence model, except the variance <inline-formula id="IEq24"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma_{S}^{2}$$\end{document}</tex-math><mml:math id="M60"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq24.gif"/></alternatives></inline-formula> was assigned a half-Normal prior<disp-formula id="Eque"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma_{S}^{2} \sim {\mathcal{N}}\left( {0, 5} \right){\text{II}}_{{\left( {0,\infty } \right)}}$$\end{document}</tex-math><mml:math id="M62" display="block"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:mfenced><mml:msub><mml:mtext>II</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>∞</mml:mi></mml:mrow></mml:mfenced></mml:msub></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Eque.gif" position="anchor"/></alternatives></disp-formula>instead of an inverse Gamma distribution, where the indicator function II<inline-formula id="IEq25"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{II}}_{{\left( {0,\infty } \right)}} = 1$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:msub><mml:mtext>II</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>∞</mml:mi></mml:mrow></mml:mfenced></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq25.gif"/></alternatives></inline-formula> if <inline-formula id="IEq26"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0 &lt; \sigma_{S}^{2}$$\end{document}</tex-math><mml:math id="M66"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq26.gif"/></alternatives></inline-formula>. The priors for the intercept, regression coefficients, and spatial smoothing parameter <inline-formula id="IEq27"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\rho$$\end{document}</tex-math><mml:math id="M68"><mml:mi>ρ</mml:mi></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq27.gif"/></alternatives></inline-formula> were assigned weakly informative priors, namely,<disp-formula id="Equf"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{*{20}c} {\alpha_{t} \text{ }\sim { \mathcal{N}}\left( {0, 1000} \right)} \\ {\beta_{k} \text{ }\sim { \mathcal{N}}\left( {0, 1000} \right) \quad {\text{for }}k = 1, \ldots ,K} \\ {\rho \sim {\text{Uniform}}\left( {0, 1} \right).} \\ \end{array}$$\end{document}</tex-math><mml:math id="M70" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mspace width="0.333333em"/><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1000</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mspace width="0.333333em"/><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1000</mml:mn></mml:mrow></mml:mfenced><mml:mspace width="1em"/><mml:mrow><mml:mtext>for</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mi>ρ</mml:mi><mml:mo>∼</mml:mo><mml:mtext>Uniform</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equf.gif" position="anchor"/></alternatives></disp-formula>
</p>
          <p id="Par41">The rationale for the choices of these priors is explained in further detail below (see “<xref rid="Sec17" ref-type="sec">Sensitivity analyses</xref>”) The key output from this model and reported in the Atlas is the EHR, given by <inline-formula id="IEq28"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\exp \left( {S_{i} } \right)$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:mo>exp</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq28.gif"/></alternatives></inline-formula>.</p>
        </sec>
        <sec id="Sec15">
          <title>Uncertainty and posterior probability differences</title>
          <p id="Par42">The statistical models not only smooth the estimates spatially so as to provide more realistic estimates of the cancer burden in Australia, but they also reduce the uncertainty around these estimates. This is especially true when the observed cases are zero, effectively yielding an observed SIR, i.e. <inline-formula id="IEq29"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y_{i} /E_{i}$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq29.gif"/></alternatives></inline-formula>, with unbounded uncertainty about the true value (keeping in mind that the residential population is at least 5, and that the SIR is modelled on the log-scale). This is true for the EHR too, at least conceptually. Presenting the uncertainty in the Atlas is important since similar point estimates with different levels of uncertainty can lead to different inferences.</p>
          <p id="Par43">In the Atlas, two different aspects of uncertainty are examined. The first aspect is the precision of the posterior point estimates of incidence and relative survival, which is quantified using credible intervals (CrIs), specifically 60% and 80% CrIs. Providing two credible interval widths gives greater information, and 80% is recognised as an appropriate choice for Bayesian models [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
          <p id="Par44">The second aspect relates to the probability that an estimate is different from the Australian average, taking into account its uncertainty. The posterior probability that the estimate in the <inline-formula id="IEq30"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M76"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq30.gif"/></alternatives></inline-formula> area is greater than 1 is given by<disp-formula id="Equg"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$PP_{{i,{\text{high}}}} = \frac{1}{M}\mathop \sum \limits_{m = 1}^{M} {\text{II}}\left( {A_{i}^{\left( m \right)} &gt; 1} \right)$$\end{document}</tex-math><mml:math id="M78" display="block"><mml:mrow><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>high</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>M</mml:mi></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mtext>II</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msubsup><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12942_2019_185_Article_Equg.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq31"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$A_{i}^{\left( m \right)}$$\end{document}</tex-math><mml:math id="M80"><mml:msubsup><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq31.gif"/></alternatives></inline-formula> is the <inline-formula id="IEq32"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$m{\text{th}}$$\end{document}</tex-math><mml:math id="M82"><mml:mrow><mml:mi>m</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq32.gif"/></alternatives></inline-formula> MCMC estimate (SIR or EHR) for the <inline-formula id="IEq33"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M84"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq33.gif"/></alternatives></inline-formula> area. By symmetry, the probability of the <inline-formula id="IEq34"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i{\text{th}}$$\end{document}</tex-math><mml:math id="M86"><mml:mrow><mml:mi>i</mml:mi><mml:mtext>th</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq34.gif"/></alternatives></inline-formula> area’s estimate being less than 1 is <inline-formula id="IEq35"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$PP_{{i,{\text{low}}}} = 1 - PP_{{i,{\text{high}}}}$$\end{document}</tex-math><mml:math id="M88"><mml:mrow><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>low</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>high</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq35.gif"/></alternatives></inline-formula>. Therefore, the confidence that the estimate is substantively different to 1 is given by <inline-formula id="IEq36"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left| {PP_{{i,{\text{high}}}} - PP_{{i,{\text{low}}}} } \right|$$\end{document}</tex-math><mml:math id="M90"><mml:mfenced close="|" open="|" separators=""><mml:mrow><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>high</mml:mtext></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>low</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq36.gif"/></alternatives></inline-formula> which is equivalent to the scaled probability <inline-formula id="IEq37"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2\left| {PP_{{i,{\text{high}}}} - 0.5} \right|$$\end{document}</tex-math><mml:math id="M92"><mml:mrow><mml:mn>2</mml:mn><mml:mfenced close="|" open="|" separators=""><mml:mrow><mml:mi>P</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mtext>high</mml:mtext></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq37.gif"/></alternatives></inline-formula>, referred to as the difference in posterior probabilities (DPP).</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec16">
      <title>Computation</title>
      <p id="Par45">An increasing range of algorithms is available for spatial models. Popular examples include MCMC simulation [<xref ref-type="bibr" rid="CR43">43</xref>] and approximations such as integrated nested Laplace approximation (INLA) [<xref ref-type="bibr" rid="CR44">44</xref>]. For the Atlas, we chose an MCMC approach to estimate the posterior distributions because it is easier to quantify the uncertainty of the posterior estimates compared to alternative approaches like INLA. This grants practical advantages in estimating comparative statistics and visualising the uncertainty as discussed below. The incidence models were implemented in R [<xref ref-type="bibr" rid="CR45">45</xref>] using the CARBayes package v5.0 [<xref ref-type="bibr" rid="CR46">46</xref>] while the relative survival models were implemented in WinBUGS [<xref ref-type="bibr" rid="CR47">47</xref>] interfaced with R using the R2WinBUGS package [<xref ref-type="bibr" rid="CR48">48</xref>].</p>
      <p id="Par46">For both incidence and relative survival models, the MCMC chains had a burn-in of 50,000 followed by an additional 100,000 iterations, keeping every 10th iteration to reduce dependence between samples, resulting in a posterior sample size of 10,000. Convergence of these chains was assessed by visual inspection of trace and density plots for selected parameters and areas (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), and more formally using the Geweke diagnostic test [<xref ref-type="bibr" rid="CR49">49</xref>]. Areas with a Geweke p-value &lt; 0.01 were flagged to be examined visually for evidence of convergence. These tests indicated that the burn-in was sufficient.<fig id="Fig1"><label>Fig. 1</label><caption><p>Example trace and density plots used to assess convergence of the MCMC chains for the log-SIR for two selected SA2s: <bold>a</bold> trace plot and <bold>b</bold> density plot for a model run on simulated data showing an example of lack of convergence; and <bold>c</bold> trace plot and <bold>d</bold> density plot for the Leroux incidence model for one selected cancer and SA2, showing convergence of the estimates used in the Atlas</p></caption><graphic xlink:href="12942_2019_185_Fig1_HTML" id="MO10"/></fig>
</p>
    </sec>
    <sec id="Sec17">
      <title>Sensitivity analyses</title>
      <p id="Par47">The priors for the incidence model correspond to the default priors for those parameters in CARBayes. The same priors were initially used for the regression coefficients and spatial smoothing parameter in the relative survival model, but subsequently made less vague due to convergence issues.</p>
      <p id="Par48">Moreover, a sensitivity analysis was conducted to determine how influential the priors were on the posterior estimates. Our analysis revealed that the estimates were insensitive to the prior choices, except for the prior on the variance of the spatial random effects, <inline-formula id="IEq38"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma_{S}^{2}$$\end{document}</tex-math><mml:math id="M94"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq38.gif"/></alternatives></inline-formula>, for the relative survival model which tended to be more influential when the data were more sparse (i.e. for rarer cancers). For the incidence models, the sensitivity analyses for <inline-formula id="IEq39"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma_{S}^{2}$$\end{document}</tex-math><mml:math id="M96"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq39.gif"/></alternatives></inline-formula> revealed that the estimates were fairly robust to this prior choice.</p>
      <p id="Par49">Over 50 different prior specifications were considered for <inline-formula id="IEq40"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma_{S}^{2}$$\end{document}</tex-math><mml:math id="M98"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq40.gif"/></alternatives></inline-formula> in the relative survival model, including gamma, inverse gamma, and half-Normal distributions with different parameter values. Notable examples include the <inline-formula id="IEq41"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal{I}\mathcal{G}}\left( {1, 0.01} \right)$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mrow><mml:mi mathvariant="script">I</mml:mi><mml:mi mathvariant="script">G</mml:mi></mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq41.gif"/></alternatives></inline-formula> prior for comparison to the incidence model, and half-Normal priors corresponding to Normal priors with variances of 3, 5, 7.5, and 10 each truncated at zero. The inverse gamma prior was too vague, leading to under-smoothing, as was the half-Normal prior with a variance of 10. The other three half-Normal priors gave reasonable results, showing slight variations in the degree of smoothing, so the <inline-formula id="IEq42"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathcal{N}}\left( {0, 5} \right){\text{II}}_{{\left( {0,\infty } \right)}}$$\end{document}</tex-math><mml:math id="M102"><mml:mrow><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:mfenced><mml:msub><mml:mtext>II</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>∞</mml:mi></mml:mrow></mml:mfenced></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq42.gif"/></alternatives></inline-formula> prior was chosen as a compromise between conservative estimates and estimates which will show genuine differences between areas.</p>
    </sec>
    <sec id="Sec18">
      <title>Level of evidence for spatial variation</title>
      <p id="Par50">This was assessed using Tango’s Maximised Excess Events Test (MEET) global clustering test [<xref ref-type="bibr" rid="CR50">50</xref>], which has been shown to perform well across a variety of datasets [<xref ref-type="bibr" rid="CR51">51</xref>]. The input data required for this test is the modelled counts (i.e. from the model results, the number of diagnoses or excess deaths per area) and the expected counts (as input into the Bayesian model). As it is expected to consider up to half the total area, our maximum distance of examination was 2000 km. The p-value from Tango’s MEET was divided into four categories, consistent with previous analyses [<xref ref-type="bibr" rid="CR52">52</xref>], being strong (p-value &lt; 0.01), moderate (p-value 0.01 to &lt; 0.05), weak (p-value 0.05 to &lt; 0.10) and none (p-value 0.10+). Tango’s MEET uses Monte Carlo methods, so to help ensure our categorisation was appropriate, we calculated Tango’s MEET three times, reporting only the most conservative category. Only one cancer and sex combination had different categories for diagnoses, and four for excess deaths. If there is one bar or less for the level of evidence, this indicates that overall there is no meaningful evidence that the estimate for this cancer type and sex varies across the country. There may still be some individual areas that differ from the national average, but given the lack of evidence for overall variation, these individual differences should be interpreted with greater caution.</p>
    </sec>
    <sec id="Sec19">
      <title>Visualisation</title>
      <p id="Par51">The Atlas consists of several visual components. The main component is the map of SA2s shaded according to point estimates of the SIR/EHR. Also included are visualisations which clarify the uncertainty around those estimates and whether they represent real differences to the Australian average, and visualisations to better illustrate spatial patterns from a national perspective. At the start of the Atlas development, we initiated an independent scoping process to obtain, among other things, a consensus about the key users for the Atlas, and then combined these into four target groups—the general public, policy makers, scientific researchers and health practitioners. When designing the presentation of the results from the statistical analysis in the Atlas, consideration was given to why each group would use the atlas and their skill levels. Feedback from people within these user groups was obtained during the development of the Atlas through focus groups and stakeholder workshops.</p>
      <sec id="Sec20">
        <title>Maps</title>
        <p id="Par52">For each SA2, the models generate a posterior distribution each of the unknown parameters, including the two main quantities of interest, the <inline-formula id="IEq43"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SIR_{i} = \exp \left( {\theta_{i} } \right)$$\end{document}</tex-math><mml:math id="M104"><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>exp</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq43.gif"/></alternatives></inline-formula> and <inline-formula id="IEq44"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$EHR_{i} = \exp \left( {S_{i} } \right)$$\end{document}</tex-math><mml:math id="M106"><mml:mrow><mml:mi>E</mml:mi><mml:mi>H</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>exp</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq44.gif"/></alternatives></inline-formula>. To avoid any undue influence from outliers, the median of the 10,000 monitored MCMC iterations is used in the maps.</p>
        <sec id="Sec21">
          <title>Colour schemes</title>
          <p id="Par53">The estimates <inline-formula id="IEq45"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SIR_{i}$$\end{document}</tex-math><mml:math id="M108"><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq45.gif"/></alternatives></inline-formula> and <inline-formula id="IEq46"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$EHR_{i}$$\end{document}</tex-math><mml:math id="M110"><mml:mrow><mml:mi>E</mml:mi><mml:mi>H</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12942_2019_185_Article_IEq46.gif"/></alternatives></inline-formula> for a given area were intended to be interpreted in relation to the Australian average, which by construction, has an SIR and EHR of 1. To facilitate this interpretation at a national level, so that the spatial patterns of cancer, if any exist, are easily observable on the Atlas maps, the estimates were mapped according to a diverging colour gradient where yellow represents the Australian average, darker shades of orange/red indicate SA2s with an estimate above the Australian average (higher than average risk), and shades of blue indicate SA2s with an estimate below the Australian average (lower than average risk). Both SIRs and EHRs were mapped to the same spectrum of colours to facilitate comparison of spatial patterns between incidence and survival estimates. The colour gradients were linear on the log scale, with the darkest red reflecting an SIR of 1.5 (a 50% higher risk of diagnosis or death within 5 years than the average) or greater, and dark blue beginning at the inverse point (≈ 0.67). In making the colour selection, we considered the needs of people with various forms of colour blindness. A Colour Blindness Simulator (<ext-link ext-link-type="uri" xlink:href="https://www.color-blindness.com/coblis-color-blindness-simulator/">https://www.color-blindness.com/coblis-color-blindness-simulator/</ext-link>) provided substantial evidence that the chosen colour scheme was still interpretable by most forms of colour blindness, apart from monochromatism.</p>
        </sec>
        <sec id="Sec22">
          <title>Transparency layer</title>
          <p id="Par54">So that imprecise estimates do not give the impression of important differences, a second layer with varying degrees of opacity was also developed and displayed (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). This has the pale-yellow colour of the Australian average in increasing opacity (0% if an estimate has a DPP of 1, 100% if an estimate has a DPP of 0), so that estimates with very high uncertainty were less visually distinguishable from the Australian average, regardless of their median values.<fig id="Fig2"><label>Fig. 2</label><caption><p>Partial map of liver cancer incidence for females with <bold>a</bold> transparency overlay disabled, and <bold>b</bold> transparency overlay enabled (default option)</p></caption><graphic xlink:href="12942_2019_185_Fig2_HTML" id="MO11"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec23">
        <title>Graphs</title>
        <sec id="Sec24">
          <title>Summary plots for large regions</title>
          <p id="Par55">The nationwide patterns can be difficult to visualise geographically due to small SA2s, especially in urban areas, which are not visible without zooming in. To overcome this, summary plots showing the distribution of SA2-specific estimates were developed so that all of Australia could be represented, either in its entirety (quintiles of area-based socioeconomic groups using the Index of Relative Socio-economic Advantage and Disadvantage [<xref ref-type="bibr" rid="CR53">53</xref>], remoteness areas (categories of the physical distance of a location from the nearest areas of concentrated urban development with populations of 200 people or more) [<xref ref-type="bibr" rid="CR54">54</xref>], or state and territory boundaries), or focused on regions which were difficult to see on the map (greater capital city areas [<xref ref-type="bibr" rid="CR55">55</xref>]). An example is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Example of the summary plots for large regions, showing liver cancer incidence for females by SA2 as <bold>a</bold> a percentage of SA2-specific estimates, and <bold>b</bold> a distribution (boxplot) of SA2-specific estimates</p></caption><graphic xlink:href="12942_2019_185_Fig3_HTML" id="MO12"/></fig>
</p>
        </sec>
        <sec id="Sec25">
          <title>V-plots</title>
          <p id="Par56">A V-plot (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) was developed as a new method for combing two pieces of information, namely the area-specific SIR/EHR estimates and the probability that these estimates are different from the Australian average. The x-axis compares the posterior median SIR/EHR of each area to the Australian average, while the y-axis is the posterior probability that the true incidence/relative survival for an area is different from the Australian average; this is given by the DPP. Estimates near the top of the V-plot are likely to reflect a real difference from the Australian average, while estimates near the bottom of the V-plot are unlikely to be a real difference.<fig id="Fig4"><label>Fig. 4</label><caption><p>Example of the V-plot and wave plot showing liver cancer incidence for males for two selected SA2s</p></caption><graphic xlink:href="12942_2019_185_Fig4_HTML" id="MO13"/></fig>
</p>
        </sec>
        <sec id="Sec26">
          <title>Wave plots</title>
          <p id="Par57">The precision around a posterior estimate of the SIR (reflected by the 60% and 80% CrIs), was summarised visually by a plot of the empirical density for the logarithm of the SIR, where the labels were adjusted to reflect the scale of the SIR (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Similarly for the EHR. The representation on the log-scale addresses the problems associated with densities for ratio scale parameters, most notably the apparent differences in the area under the curve resulting from the non-linear intervals. Since these densities are not true densities, but are analogous in their interpretation, we refer to them as “wave plots”.<fig id="Fig5"><label>Fig. 5</label><caption><p>Example view of the Australian Cancer Atlas showing the geographic variation of prostate cancer incidence</p></caption><graphic xlink:href="12942_2019_185_Fig5_HTML" id="MO14"/></fig>
</p>
        </sec>
      </sec>
    </sec>
  </sec>
  <sec id="Sec27">
    <title>Results</title>
    <p id="Par58">The results of the statistical model and visualisation development were published through the release of the Australian Cancer Atlas (<ext-link ext-link-type="uri" xlink:href="https://atlas.cancer.org.au">https://atlas.cancer.org.au</ext-link>) in September, 2018. The Australian Cancer Atlas provides the first freely available, digital, interactive picture of cancer incidence and survival at the small geographical level across Australia with a focus on incorporating uncertainty, while also providing the tools necessary for accurate estimation and appropriate interpretation and decision making. The main user interface of the Atlas is illustrated in Fig. <xref rid="Fig5" ref-type="fig">5</xref>.</p>
  </sec>
  <sec id="Sec28">
    <title>Discussion</title>
    <p id="Par59">The Australian Cancer Atlas is the first comprehensive, interactive digital cancer atlas based on small areas and utilising spatial smoothing to describe geographical patterns of cancer incidence and survival across Australia. One of the key objectives of the Atlas was to motivate new research to gain a better understanding of why geographical variation exists. Its success will be measured in part by how widely the Australian Cancer Atlas is used by key stakeholders, including members of the community, researchers, clinicians, and government, both as a source of information and to guide research and inform decision making.</p>
    <p id="Par60">Towards this aim, we plan an ongoing program of development and research. Future versions of the Atlas are planned to incorporate information about how geographical patterns have changed over time, new indicators such as cancer screening, diagnostic tests, and cancer treatment, and alternative visualisations such as cartograms which alleviate overemphasis of spatial patterns exhibited by large but lesser populated areas.</p>
    <p id="Par61">It is also hoped that the Atlas will provide motivation and opportunity for a better understanding of why geographical variation exists for each type of cancer. These investigations will need to consider in more detail the characteristics of people living within areas, the stage and other clinical characteristics of the cancer, treatment patterns, and the distribution of known cancer risk factors and cancer screening behaviour. They will also incorporate ecological modelling to identify associations between key area-level factors and geographical patterns such as remoteness, area disadvantage and access to services. A multidisciplinary approach will be crucial to meet these goals, and it is hoped that the Atlas provides motivation and opportunity for different research groups to collaborate and combine existing data at the small area level.</p>
  </sec>
  <sec id="Sec29">
    <title>Conclusions</title>
    <p id="Par62">Since its release in September 2018, the Australian Cancer Atlas has brought new insights about geographical cancer patterns across Australia. It has already motivated new collaborations within Australia and internationally to better quantify and understand the geographical patterns of cancer indicators, and will continue to form the foundation of an ongoing research program incorporating innovative statistical models and visualisations to better quantify the extent and characteristics of the geographical variation, and the reasons why it exists.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>ACD</term>
        <def>
          <p id="Par5">Australian Cancer Database</p>
        </def>
      </def-item>
      <def-item>
        <term>ASGS</term>
        <def>
          <p id="Par6">Australian Statistical Geography Standard</p>
        </def>
      </def-item>
      <def-item>
        <term>CAR</term>
        <def>
          <p id="Par7">conditional autoregressive</p>
        </def>
      </def-item>
      <def-item>
        <term>CrI</term>
        <def>
          <p id="Par8">credible interval</p>
        </def>
      </def-item>
      <def-item>
        <term>DPP</term>
        <def>
          <p id="Par9">difference in posterior probabilities</p>
        </def>
      </def-item>
      <def-item>
        <term>EHR</term>
        <def>
          <p id="Par10">excess hazard ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>ICD</term>
        <def>
          <p id="Par11">International Classification of Diseases</p>
        </def>
      </def-item>
      <def-item>
        <term>MCMC</term>
        <def>
          <p id="Par12">Markov Chain Monte Carlo</p>
        </def>
      </def-item>
      <def-item>
        <term>MEET</term>
        <def>
          <p id="Par13">Maximised Excess Events Test</p>
        </def>
      </def-item>
      <def-item>
        <term>SA2</term>
        <def>
          <p id="Par14">Statistical Area 2</p>
        </def>
      </def-item>
      <def-item>
        <term>SIR</term>
        <def>
          <p id="Par15">standardised incidence ratio</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The Research team acknowledge the support of the cancer registries within the Australasian Association of Cancer Registries in enabling this Cancer Atlas to proceed, and the guidance provided by members of the Project Advisory Group. The authors would also like to acknowledge the valuable contribution from the Visualisation and eResearch (ViseR) team, QUT, in developing the digital product and providing the expertise on technical matters.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>EWD, SMC conceptualisation, original preparation and revision of manuscript, visualisations; JFA conceptualisation, revision of manuscript; KLM conceptualisation, supervision, revision of manuscript; PDB conceptualisation, supervision, original preparation and revision of manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>The Australian Cancer Atlas is a collaborative study funded by the FrontierSI (formerly the Cooperative Research Centre for Spatial Information), Cancer Council Queensland, Australian Institute of Health and Welfare and Queensland University of Technology. The Atlas has additional support from the Centre for Research Excellence in Prostate Cancer Survivorship. It has been endorsed by the Australasian Association of Cancer Registries and Cancer Council Australia, and investigators access expertise from the Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets generated during the current study are available for download via the Australian Cancer Atlas (<ext-link ext-link-type="uri" xlink:href="https://atlas.cancer.org.au">https://atlas.cancer.org.au</ext-link>). The original data that support the findings of this study are available from the Australian Cancer Database, Australian Institute of Health and Welfare, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. With appropriate ethics and data custodian approvals, these data can be obtained from the Australian Institute of Health and Welfare.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par63">Ethical approval to undertake this study was obtained from research ethics committees in New South Wales (NSW) (NSW Population &amp; Health Services Research Ethics Committee, Ref: 2017/HREC0203), Queensland (Queensland University of Technology Human Research Ethics Committee, Ref. 1600000880), and the two territories (Australian Capital Territory (ACT) Health Human Research Ethics Committee, Ref. ETHLR.16.235 and Human Research Ethics Committee for the Northern Territory Department of Health and Menzies School of Health Research, Ref: 2016-2720). Approval to extract the data was obtained from each State and Territory data custodian.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par64">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par65">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baade</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>XQ</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Dunn</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chambers</surname>
            <given-names>SK</given-names>
          </name>
        </person-group>
        <article-title>Geographic disparities in prostate cancer outcomes—review of international patterns</article-title>
        <source>Asian Pac J Cancer Prev</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>3</issue>
        <fpage>1259</fpage>
        <lpage>1275</lpage>
        <pub-id pub-id-type="doi">10.7314/APJCP.2015.16.3.1259</pub-id>
        <pub-id pub-id-type="pmid">25735366</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dwyer-Lindgren</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bertozzi-Villa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stubbs</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Morozoff</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mackenbach</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>van Lenthe</surname>
            <given-names>FJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inequalities in life expectancy among US counties, 1980 to 2014</article-title>
        <source>JAMA Intern Med</source>
        <year>2017</year>
        <volume>177</volume>
        <issue>7</issue>
        <fpage>1003</fpage>
        <lpage>1011</lpage>
        <pub-id pub-id-type="doi">10.1001/jamainternmed.2017.0918</pub-id>
        <pub-id pub-id-type="pmid">28492829</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Menigoz</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nathan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Heesch</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Turrell</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Neighbourhood disadvantage, geographic remoteness and body mass index among immigrants to Australia: a national cohort study 2006–2014</article-title>
        <source>PLoS ONE</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>1</issue>
        <fpage>e0191729</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0191729</pub-id>
        <pub-id pub-id-type="pmid">29360878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padilla</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Kihal-Talantikit</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Perez</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Deguen</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Use of geographic indicators of healthcare, environment and socioeconomic factors to characterize environmental health disparities</article-title>
        <source>Environ Health</source>
        <year>2016</year>
        <volume>15</volume>
        <issue>1</issue>
        <fpage>79</fpage>
        <pub-id pub-id-type="doi">10.1186/s12940-016-0163-7</pub-id>
        <pub-id pub-id-type="pmid">27449640</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Youl</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Dasgupta</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Youlden</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Aitken</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Garvey</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zorbas</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A systematic review of inequalities in psychosocial outcomes for women with breast cancer according to residential location and Indigenous status in Australia</article-title>
        <source>Psychooncology</source>
        <year>2016</year>
        <volume>25</volume>
        <issue>10</issue>
        <fpage>1157</fpage>
        <lpage>1167</lpage>
        <pub-id pub-id-type="doi">10.1002/pon.4124</pub-id>
        <pub-id pub-id-type="pmid">26989048</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <mixed-citation publication-type="other">Public Health Information Development Unit. Social Health Atlas of Australia: Population Health Areas 2019. <ext-link ext-link-type="uri" xlink:href="http://phidu.torrens.edu.au/social-healthatlases/data#social-health-atlas-of-australia-population-health-areas">http://phidu.torrens.edu.au/social-healthatlases/data#social-health-atlas-of-australia-population-health-areas</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <mixed-citation publication-type="other">Australian Institute of Health and Welfare. Cancer incidence and mortality in Australia by small geographic areas, Cat. no. CAN 108; 2018. <ext-link ext-link-type="uri" xlink:href="http://www.aihw.gov.au/reports/cancer/cancer-incidence-mortality-small-geographic-areas/data">http://www.aihw.gov.au/reports/cancer/cancer-incidence-mortality-small-geographic-areas/data</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <mixed-citation publication-type="other">Small Area Health Statistics Unit. The Environment and Health Atlas of England and Wales. <ext-link ext-link-type="uri" xlink:href="http://www.envhealthatlas.co.uk/homepage/">http://www.envhealthatlas.co.uk/homepage/</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <mixed-citation publication-type="other">Geographic Information Systems and Science for Cancer Control, National Cancer Institute. National Cancer Atlas Application. 2019. <ext-link ext-link-type="uri" xlink:href="https://gis.cancer.gov/canceratlas/app/">https://gis.cancer.gov/canceratlas/app/</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">U.S. Cancer Statistics Working Group. United States Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999–2016): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. <ext-link ext-link-type="uri" xlink:href="https://gis.cdc.gov/Cancer/USCS/DataViz.html">https://gis.cdc.gov/Cancer/USCS/DataViz.html</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <mixed-citation publication-type="other">Carlos III Institute of Health, National Center for Epidemiology. Interactive epidemiological information system (ARIADNA). <ext-link ext-link-type="uri" xlink:href="http://ariadna.cne.isciii.es/evindex.html">http://ariadna.cne.isciii.es/evindex.html</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <mixed-citation publication-type="other">Cancer Council Queensland, Queensland University of Technology, FrontierSI. Australian Cancer Atlas. Version 09-2018. Brisbane: Cancer Council Queensland, QUT, FrontierSI. 2018. <ext-link ext-link-type="uri" xlink:href="https://atlas.cancer.org.au">https://atlas.cancer.org.au</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Australian Bureau of Statistics</collab>
        </person-group>
        <source>Australian Statistical Geography Standard (ASGS): vol. 1. Main structure and greater capital city statistical areas</source>
        <year>2011</year>
        <publisher-loc>Canberra</publisher-loc>
        <publisher-name>ABS</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): correspondences 2011, ‘Statistical Local Area 2011 to Statistical Area Level 2 2011’, data cube: Excel spreadsheet, cat. no. 1270.0.55.006; 2013<ext-link ext-link-type="uri" xlink:href="http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.006July%202011">www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.006July%202011</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>World Health Organization</collab>
        </person-group>
        <source>International statistical classification of diseases and related health problems 10th Revision (ICD-10): 2016 version</source>
        <year>2016</year>
        <publisher-loc>Geneva</publisher-loc>
        <publisher-name>WHO</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Esteve</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Benhamou</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <source>Statistical methods in cancer research volume IV: descriptive epidemiology</source>
        <year>1994</year>
        <publisher-loc>Lyon</publisher-loc>
        <publisher-name>International Agency for Research on Cancer</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pickle</surname>
            <given-names>LW</given-names>
          </name>
        </person-group>
        <article-title>A history and critique of U.S. mortality atlases</article-title>
        <source>Spat Spatiotemporal Epidemiol</source>
        <year>2009</year>
        <volume>1</volume>
        <issue>1</issue>
        <fpage>3</fpage>
        <lpage>17</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sste.2009.07.004</pub-id>
        <pub-id pub-id-type="pmid">22749412</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dickman</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Adami</surname>
            <given-names>HO</given-names>
          </name>
        </person-group>
        <article-title>Interpreting trends in cancer patient survival</article-title>
        <source>J Intern Med</source>
        <year>2006</year>
        <volume>260</volume>
        <issue>2</issue>
        <fpage>103</fpage>
        <lpage>117</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1365-2796.2006.01677.x</pub-id>
        <pub-id pub-id-type="pmid">16882274</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brenner</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hakulinen</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Up-to-date long-term survival curves of patients with cancer by period analysis</article-title>
        <source>J Clin Oncol</source>
        <year>2002</year>
        <volume>20</volume>
        <issue>3</issue>
        <fpage>826</fpage>
        <lpage>832</lpage>
        <pub-id pub-id-type="doi">10.1200/JCO.2002.20.3.826</pub-id>
        <pub-id pub-id-type="pmid">11821467</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <mixed-citation publication-type="other">Australian Institute of Health and Welfare. Australian Cancer Database Canberra: AIHW; 2018. <ext-link ext-link-type="uri" xlink:href="https://www.aihw.gov.au/about-our-data/our-datacollections/australian-cancer-database">https://www.aihw.gov.au/about-our-data/our-datacollections/australian-cancer-database</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">Australian Bureau of Statistics. ABS.Stat Dataset: ERP by Statistical Areas Level 2 (SA2) geographical areas (ASGS 2011), age and sex, 2001 to 2016 ABS Cat No 3235.0. Australian Bureau of Statistics. Released August 2017. <ext-link ext-link-type="uri" xlink:href="http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3235.02016">http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3235.02016</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <mixed-citation publication-type="other">Queensland Government. National death data 2018. <ext-link ext-link-type="uri" xlink:href="https://www.qld.gov.au/law/births-deaths-marriages-and-divorces/data/national-data">https://www.qld.gov.au/law/births-deaths-marriages-and-divorces/data/national-data</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tobler</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>A computer movie simulating urban growth in the Detroit region</article-title>
        <source>Econ Geogr</source>
        <year>1970</year>
        <volume>46</volume>
        <issue>2</issue>
        <fpage>234</fpage>
        <lpage>240</lpage>
        <pub-id pub-id-type="doi">10.2307/143141</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hampton</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Serre</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Gesink</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Pilcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>WC</given-names>
          </name>
        </person-group>
        <article-title>Adjusting for sampling variability in sparse data: geostatistical approaches to disease mapping</article-title>
        <source>Int J Health Geogr</source>
        <year>2011</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>54</fpage>
        <pub-id pub-id-type="doi">10.1186/1476-072X-10-54</pub-id>
        <pub-id pub-id-type="pmid">21978359</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Besag</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Spatial interaction and the statistical analysis of lattice systems</article-title>
        <source>J R Stat Soc Ser B</source>
        <year>1974</year>
        <volume>36</volume>
        <issue>2</issue>
        <fpage>192</fpage>
        <lpage>225</lpage>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Banerjee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carlin</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Gelfand</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <source>Hierarchical modeling and analysis for spatial data</source>
        <year>2014</year>
        <edition>2</edition>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>Chapman and Hall/CRC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>GD</given-names>
          </name>
        </person-group>
        <article-title>Small area mapping of prostate cancer incidence in New York State (USA) using fully Bayesian hierarchical modelling</article-title>
        <source>Int J Health Geogr</source>
        <year>2004</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>29</fpage>
        <pub-id pub-id-type="doi">10.1186/1476-072X-3-29</pub-id>
        <pub-id pub-id-type="pmid">15588279</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Congdon</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <source>Applied Bayesian hierarchical methods</source>
        <year>2010</year>
        <publisher-loc>London</publisher-loc>
        <publisher-name>Chapman and Hall/CRC Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duncan</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Mengersen</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Spatial smoothing in Bayesian models: a comparison of weights matrix specifications and their impact on inference</article-title>
        <source>Int J Health Geogr</source>
        <year>2017</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>47</fpage>
        <pub-id pub-id-type="doi">10.1186/s12942-017-0120-x</pub-id>
        <pub-id pub-id-type="pmid">29246157</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wall</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <article-title>A close look at the spatial structure implied by the CAR and SAR models</article-title>
        <source>J Stat Plan Inference</source>
        <year>2004</year>
        <volume>121</volume>
        <issue>2</issue>
        <fpage>311</fpage>
        <lpage>324</lpage>
        <pub-id pub-id-type="doi">10.1016/S0378-3758(03)00111-3</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Best</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Conlon</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Bernardo</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Dawid</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>AFM</given-names>
          </name>
        </person-group>
        <article-title>Bayesian models for spatially correlated disease and exposure data</article-title>
        <source>Bayesian statistics 6: Proceedings of the sixth Valencia international meeting</source>
        <year>1998</year>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>Oxford University Press</publisher-name>
        <fpage>131</fpage>
        <lpage>156</lpage>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Earnest</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mengersen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Summerhayes</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Beard</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Evaluating the effect of neighbourhood weight matrices on smoothing properties of Conditional Autoregressive (CAR) models</article-title>
        <source>Int J Health Geogr</source>
        <year>2007</year>
        <volume>6</volume>
        <fpage>54</fpage>
        <pub-id pub-id-type="doi">10.1186/1476-072X-6-54</pub-id>
        <pub-id pub-id-type="pmid">18045503</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">Conlon EM, Waller LA. Flexible neighborhood structures in hierarchical models for disease mapping. Report 1998–018. Minneapolis: University of Minnesota, Division of Biostatistics; 1998.</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Rue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Held</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <source>Gaussian Markov random fields: theory and applications</source>
        <year>2005</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>CRC Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bell</surname>
            <given-names>KP</given-names>
          </name>
          <name>
            <surname>Bockstael</surname>
            <given-names>NE</given-names>
          </name>
        </person-group>
        <article-title>Applying the generalized-moments estimation approach to spatial problems involving microlevel data</article-title>
        <source>Rev Econ Stat</source>
        <year>2000</year>
        <volume>82</volume>
        <issue>1</issue>
        <fpage>72</fpage>
        <lpage>82</lpage>
        <pub-id pub-id-type="doi">10.1162/003465300558641</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Griffith</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Arlinghaus</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>Some guidelines for specifying the geographic weights matrix contained in spatial statistical models</article-title>
        <source>Practical handbook of spatial statistics</source>
        <year>1996</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>CRC Press</publisher-name>
        <fpage>65</fpage>
        <lpage>82</lpage>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Cramb</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Duncan</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Baade</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Mengersen</surname>
            <given-names>KL</given-names>
          </name>
        </person-group>
        <source>Investigation of Bayesian spatial models</source>
        <year>2017</year>
        <publisher-loc>Brisbane</publisher-loc>
        <publisher-name>Cancer Council Queensland and Queensland University of Technology (QUT)</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leroux</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Lei</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Breslow</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Estimation of disease rates in small areas: a new mixed model for spatial dependence</article-title>
        <source>Stat Models Epidemiol Environ Clin Trials</source>
        <year>1999</year>
        <volume>116</volume>
        <fpage>179</fpage>
        <lpage>191</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-4612-1284-3_4</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Besag</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>York</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mollié</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Bayesian image restoration with application in spatial statistics</article-title>
        <source>Ann Inst Stat Math</source>
        <year>1991</year>
        <volume>43</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1007/BF00116466</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Best</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>A comparison of Bayesian spatial models for disease mapping</article-title>
        <source>Stat Methods Med Res</source>
        <year>2005</year>
        <volume>14</volume>
        <issue>1</issue>
        <fpage>35</fpage>
        <lpage>59</lpage>
        <pub-id pub-id-type="doi">10.1191/0962280205sm388oa</pub-id>
        <pub-id pub-id-type="pmid">15690999</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fairley</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>West</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Manda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing</article-title>
        <source>Br J Cancer</source>
        <year>2008</year>
        <volume>99</volume>
        <issue>11</issue>
        <fpage>1786</fpage>
        <lpage>1793</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.bjc.6604757</pub-id>
        <pub-id pub-id-type="pmid">18985045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Richardson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Best</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Elliott</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Interpreting posterior relative risk estimates in disease-mapping studies</article-title>
        <source>Environ Health Perspect</source>
        <year>2004</year>
        <volume>112</volume>
        <issue>9</issue>
        <fpage>1016</fpage>
        <lpage>1025</lpage>
        <pub-id pub-id-type="doi">10.1289/ehp.6740</pub-id>
        <pub-id pub-id-type="pmid">15198922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Metropolis</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rosenbluth</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Rosenbluth</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Teller</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Teller</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Equations of state calculations by fast computing machine</article-title>
        <source>J Chem Phys</source>
        <year>1953</year>
        <volume>21</volume>
        <issue>6</issue>
        <fpage>1087</fpage>
        <lpage>1092</lpage>
        <pub-id pub-id-type="doi">10.1063/1.1699114</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Martino</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chopin</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations</article-title>
        <source>J R Stat Soc Ser B</source>
        <year>2009</year>
        <volume>71</volume>
        <issue>2</issue>
        <fpage>319</fpage>
        <lpage>392</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-9868.2008.00700.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>R Core Team</collab>
        </person-group>
        <source>R: a language and environment for statistical computing</source>
        <year>2017</year>
        <publisher-loc>Vienna</publisher-loc>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>CARBayes: an R package for Bayesian spatial modeling with conditional autoregressive priors</article-title>
        <source>J Stat Softw</source>
        <year>2013</year>
        <volume>55</volume>
        <issue>13</issue>
        <fpage>1</fpage>
        <lpage>24</lpage>
        <pub-id pub-id-type="doi">10.18637/jss.v055.i13</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lunn</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Best</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Spiegelhalter</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility</article-title>
        <source>Stat Comput</source>
        <year>2000</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>325</fpage>
        <lpage>337</lpage>
        <pub-id pub-id-type="doi">10.1023/A:1008929526011</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sturtz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ligges</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>R2WinBUGS: a package for running WinBUGS from R</article-title>
        <source>J Stat Softw</source>
        <year>2005</year>
        <volume>12</volume>
        <issue>3</issue>
        <fpage>1</fpage>
        <lpage>16</lpage>
        <pub-id pub-id-type="doi">10.18637/jss.v012.i03</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Geweke</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Bernardo</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dawid</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>AFM</given-names>
          </name>
        </person-group>
        <article-title>Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments</article-title>
        <source>Bayesian statistics 4</source>
        <year>1992</year>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>Oxford University Press</publisher-name>
        <fpage>169</fpage>
        <lpage>193</lpage>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tango</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>A test for spatial disease clustering adjusted for multiple testing</article-title>
        <source>Stat Med</source>
        <year>2000</year>
        <volume>19</volume>
        <issue>2</issue>
        <fpage>191</fpage>
        <lpage>204</lpage>
        <pub-id pub-id-type="doi">10.1002/(SICI)1097-0258(20000130)19:2&lt;191::AID-SIM281&gt;3.0.CO;2-Q</pub-id>
        <pub-id pub-id-type="pmid">10641024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kulldorff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gregorio</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Samociuk</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>DeChello</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Cancer map patterns: are they random or not?</article-title>
        <source>Am J Prev Med</source>
        <year>2006</year>
        <volume>30</volume>
        <issue>2</issue>
        <fpage>S37</fpage>
        <lpage>S49</lpage>
        <pub-id pub-id-type="doi">10.1016/j.amepre.2005.09.009</pub-id>
        <pub-id pub-id-type="pmid">16458789</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cramb</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mengersen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Baade</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Developing the atlas of cancer in Queensland</article-title>
        <source>Int J Health Geogr</source>
        <year>2011</year>
        <volume>10</volume>
        <fpage>9</fpage>
        <pub-id pub-id-type="doi">10.1186/1476-072X-10-9</pub-id>
        <pub-id pub-id-type="pmid">21261992</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Australian Bureau of Statistics</collab>
        </person-group>
        <source>Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2011</source>
        <year>2013</year>
        <publisher-loc>Canberra</publisher-loc>
        <publisher-name>ABS</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Australian Bureau of Statistics</collab>
        </person-group>
        <source>Australian Statistical Geography Standard (ASGS): volume 5—remoteness structure, 2011</source>
        <year>2013</year>
        <publisher-loc>Canberra</publisher-loc>
        <publisher-name>ABS</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <mixed-citation publication-type="other">Australian Statistical Geography Standard (ASGS): volume 1—main structure and greater capital city statistical areas, July 2011: cat. no. 1270.0.55.001; 2011. <ext-link ext-link-type="uri" xlink:href="https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.001July%202011">https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.001July%202011</ext-link>. Accessed 27 Sept 2019.</mixed-citation>
    </ref>
  </ref-list>
</back>
